五养堂药业品牌怎么样 申请店铺

我要投票 五养堂药业在灵芝孢子粉行业中的票数:58 更新时间:2024-12-28
五养堂药业是哪个国家的品牌?「五养堂药业」是 浙江五养堂药业有限公司 旗下著名品牌。该品牌发源于浙江省丽水市,由创始人吴 * 谦在2004年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
五养堂药业怎么样

浙江五养堂药业有限公司使命是弘扬中医药五行养生文化,以现代生物科技制造灵芝、三叶青、铁皮石斛和红曲等道地药材的趁鲜口型中药饮片、保健食品、中药养生食品,以振兴中药保健食品产业和推动中药食疗食养、促进人类健康为己任,创新发展养肝(保肝明目)、养心(安心养神)、养脾(健脾益胃)、养肺(润肺养颜)、养肾(补肾益精)的五养系列健康产品,打造具有民族特色的中药保健养生和健康服务品牌。

浙江五养堂药业有限公司成立于2004年1月,其前身是浙江益圣菌物发展有限公司,由浙江省林业科学研究院、丽水市食用菌研究开发中心和吴学谦教授等40名自然人共同发起组建。2013年经严格的评估和公开挂牌交易,浙江省林业科学研究院的股份由吴学良等股东受让持有,国有股份全部退出,正式更名为“浙江五养堂药业有限公司”。

公司厂区占地面积20亩,建筑面积16000多平方米,建有中药饮片GMP车间、保健食品GMP车间、生物发酵车间、趁鲜冷冻超微破壁车间等四大健康产品生产线,目前是浙江省较大的灵芝破壁孢子粉、真菌多糖提取加工和三叶青口服型中药饮片趁鲜冷冻加工基地,产品远销欧美、日本、香港、台湾等国家和地区。

五养堂选育成功了“浙青1号“等新品种、掌握了三叶青的核心种植技术,已经申请了“一种果林地仿生套种袋式三叶青方法”等8项专利,通过三叶青趁鲜口服型加工技术改造和研发三叶青保健食品与抗菌抗炎退烧药品,拟从一产(规范种植)+二产(药品、保健食品加工)+三产(线上线下营销服务、健康服务、健康管理、健康保险、供应链管理)全产业链运作,将这一“天然的植物抗生素”三叶青产业做强做大。

五养堂将于2016年在新三板系统挂牌,并争取在1-2年内进入创新层,通过联合上市大企业搞定向增发,借助资本市场的力量将五养堂健康产业做强做大,实现百亿规模的企业梦想,并力求将五行中医药养生文化结合中国特色健康产品走向全世界。


The mission of Zhejiang wuyangtang Pharmaceutical Co., Ltd. is to carry forward the five elements health preservation culture of traditional Chinese medicine, to produce fresh Chinese herbal pieces, health food and health food of traditional Chinese medicine, such as Ganoderma lucidum, Trifolium, Dendrobium candidum and Monascus, with modern biotechnology, to revitalize the industry of health food of traditional Chinese medicine, promote the diet and nutrition of traditional Chinese medicine, and promote human health as its own duty, and innovate and develop the liver (liver protection Five series of health products, i.e. Mingmu, Yangxin (peace of mind and mind), yangpi (invigorating the spleen and stomach), Yangfei (moistening the lungs and beautifying the face) and Yangshen (invigorating the kidney and benefiting the essence), will build a brand of traditional Chinese medicine health care and health service with national characteristics. Zhejiang wuyangtang Pharmaceutical Co., Ltd. was founded in January 2004. Its predecessor is Zhejiang Yisheng fungus development Co., Ltd. which was jointly initiated and established by 40 natural persons including Zhejiang Academy of Forestry Sciences, Lishui edible fungus research and development center and Professor Wu Xueqian. In 2013, after strict evaluation and public listing, the shares of Zhejiang Academy of Forestry Sciences were transferred and held by Wu Xueliang and other shareholders, and all state-owned shares were withdrawn, officially renamed as "Zhejiang wuyangtang Pharmaceutical Co., Ltd.". The factory area of the company covers an area of 20 mu, with a building area of more than 16000 square meters. It has four major production lines for healthy products, including GMP workshop for Chinese herbal pieces, GMP workshop for health food, biological fermentation workshop, ultra-fine wall breaking workshop for fresh freezing. At present, it is a large base for the extraction and processing of Ganoderma lucidum wall breaking spore powder, fungal polysaccharide and Sanyeqing oral Chinese herbal pieces while fresh freezing in Zhejiang Province. The products are sold far Europe, America, Japan, Hong Kong, Taiwan and other countries and regions. Wuyangtang has successfully selected new varieties such as "zheqing No.1" and mastered the core planting technology of sanyeqin. It has applied for eight patents such as "a bionic interplanting bag type of sanyeqin in fruit forest". Through the technological transformation of sanyeqin taking advantage of the fresh oral processing technology and the research and development of sanyeqin health food and anti-bacterial, anti-inflammatory and fever reducing drugs, it is planned to produce from the first (standard planting) + the second (medicine, health food) Product processing) + three industries (online and offline marketing services, health services, health management, health insurance, supply chain management) operate in the whole industrial chain, making this "natural plant antibiotic" three leaf green industry stronger and bigger. Wuyangtang will be listed in the new three board system in 2016, and strive to enter the innovation layer within 1-2 years. Through joint listing of large enterprises to conduct targeted additional issuance, with the help of capital market, wuyangtang health industry will be stronger and bigger, and realize the enterprise dream of 10 billion scale, and strive to integrate the five elements of traditional Chinese medicine health culture with Chinese characteristics of health products to the world.

本文链接: https://brand.waitui.com/b6e82ab79.html 联系电话:0578-2959008,2958959

千城特选小程序码

7×24h 快讯

沪上阿姨再次向港交所递交上市申请

36氪获悉,据港交所文件,沪上阿姨(上海)实业股份有限公司再次向港交所提交上市申请书,联席保荐人为中信证券、海通国际、东方证券国际。

42分钟前

圣达生物:大股东万健投资拟减持公司不超3%股份

36氪获悉,圣达生物发布公告,公司持股19.14%的大股东天台万健投资发展中心(有限合伙)(简称“万健投资”)拟通过集中竞价、大宗交易方式减持公司股份不超过513.57万股,拟减持比例不超过公司总股本的3%。

42分钟前

美股大型科技股盘前多数下跌,特斯拉跌0.52%

36氪获悉,美股大型科技股盘前多数下跌,截至发稿,特斯拉跌0.52%,亚马逊跌0.43%,英伟达跌0.38%,奈飞跌0.37%,谷歌跌0.15%,Meta跌0.14%,微软跌0.11%,苹果涨0.12%。

42分钟前

热门中概股美股盘前多数下跌,小鹏汽车跌超3%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,小鹏汽车、名创优品跌超3%,京东跌超2%,阿里巴巴、爱奇艺、B站跌超1%,蔚来跌0.43%;理想汽车涨超2%,小马智行涨超1%。

42分钟前

央行:实施好适度宽松的货币政策 使社会融资规模、货币供应量增长同经济增长、价格总水平预期目标相匹配

36氪获悉,近日,中国人民银行发布了《中国金融稳定报告(2024)》。其中提到,实施好适度宽松的货币政策,综合运用多种货币政策工具,保持流动性充裕,使社会融资规模、货币供应量增长同经济增长、价格总水平预期目标相匹配。增强外汇市场韧性,稳定市场预期,保持人民币汇率在合理水平上的基本稳定。扩大存款保险基金及其他行业保障基金、金融稳定保障基金资金积累,发挥行业保障基金市场化、法治化处置平台作用,强化存款保险专业化风险处置职能。稳妥有效防范化解重点领域金融风险,牢牢守住不发生系统性金融风险的底线。

42分钟前

本页详细列出关于鹤芝堂的品牌信息,含品牌所属公司介绍,鹤芝堂所处行业的品牌地位及优势。
咨询